CAS: 720704-34-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 5-(5-((2,4-Dimethylthiazol-5-yl)methyl)-1,3,4-oxadiazol-2-yl)-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine REF: IN-DA00IC81CAS: 720704-34-7 | 97% | A consultar | Jue 08 May 25 |
 | GSK356278 REF: 54-BUP13141CAS: 720704-34-7 | ≥98% | 263,00 €~1.722,00 € | Vie 09 May 25 |
 | GSK356278 REF: TM-T27475CAS: 720704-34-7 | 99.43% - 99.79% | 35,00 €~1.035,00 € | Jue 10 Jul 25 |
 | GSK-356278 REF: 3D-VDB70434CAS: 720704-34-7 | Min. 95% | - - - | Producto descatalogado |
5-(5-((2,4-Dimethylthiazol-5-yl)methyl)-1,3,4-oxadiazol-2-yl)-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine
CAS:720704-34-7
Fórmula:
C21H25N7O2S
Pureza:
97%
Peso molecular:
439.5339
Ref: IN-DA00IC81
| 5mg | 157,00 € | ||
| 10mg | 181,00 € | ||
| 25mg | 489,00 € | ||
| 50mg | 597,00 € | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 8 de Mayo de 2025
Ref: 54-BUP13141
| 1g | 1.722,00 € | ||
| 25mg | 263,00 € | ||
| 50mg | 465,00 € | ||
| 100mg | 728,00 € | ||
| 200mg | 973,00 € | ||
| 500mg | 1.403,00 € |
Entrega estimada en Estados Unidos, el Viernes 9 de Mayo de 2025
GSK356278
CAS:720704-34-7
GSK356278: selective PDE4A/B/D inhibitor, pIC50~8.7, anti-inflammatory, anxiolytic, cognition-enhancing.
Fórmula:
C21H25N7O2S
Pureza:
99.43% - 99.79%
Forma y color:
Solid
Peso molecular:
439.53
Ref: TM-T27475
| 2mg | 35,00 € | ||
| 5mg | 51,00 € | ||
| 10mg | 89,00 € | ||
| 25mg | 170,00 € | ||
| 50mg | 265,00 € | ||
| 100mg | 426,00 € | ||
| 200mg | 617,00 € | ||
| 500mg | 1.035,00 € |
Entrega estimada en Estados Unidos, el Jueves 10 de Julio de 2025
GSK-356278
CAS:720704-34-7
GSK-356278 is a phosphodiesterase inhibitor that has been shown to improve the symptoms of Alzheimer's …
Fórmula:
C21H25N7O2S
Pureza:
Min. 95%
Peso molecular:
439.54 g/mol
Ref: 3D-VDB70434
| 1g | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
